Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS8 | O00214 | 8/20 | 0.56 |
| ▸ | CD209 | Q9NNX6 | 1/20 | 0.44 |
| ▸ | LGALS3 | P17931 | 7/20 | 0.40 |
| ▸ | LGALS4 | P56470 | 3/20 | 0.40 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.37 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.37 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6129339 | 0.79 | LGALS8 (0.52) | LGALS8LGALS3LGALS4LGALS9LGALS1 | |
| SCHEMBL25339181 | 0.79 | CD209 (0.40) | LGALS8CD209 | |
| SCHEMBL17283396 | 0.77 | LGALS8 (0.58) | LGALS8LGALS3LGALS4LGALS9LGALS1 | |
| SCHEMBL10972064 | 0.75 | LGALS3 (0.46) | LGALS8LGALS3LGALS4 | |
| SCHEMBL1674815 | 0.75 | LGALS8 (0.56) | LGALS8LGALS3LGALS4LGALS9LGALS1 | |
| SCHEMBL18864321 | 0.74 | LGALS8 (0.47) | LGALS8LGALS3LGALS4LGALS9LGALS1 | |
| SCHEMBL19409216 | 0.73 | LGALS8 (0.55) | LGALS8 | |
| SCHEMBL8194583 | 0.73 | LGALS8 (0.55) | LGALS8 | |
| SCHEMBL16327733 | 0.72 | LGALS8 (0.60) | LGALS8LGALS3LGALS4LGALS9LGALS1 | |
| SCHEMBL10781121 | 0.71 | LGALS8 (0.57) | LGALS8LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3356356-B1 | COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | FIRMENICH INCORPORATED (US) | 2021-05-26 | — | — | EP | disclosed |
| US-10392371-B2 | Compounds useful as modulators of TRPM8 | SENOMYX, INC. (US) | 2019-08-27 | — | — | US | disclosed |
| US-20190177308-A9 | COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | SENOMYX, INC. | 2019-06-13 | — | — | US | disclosed |
| US-20180273517-A1 | COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | SENOMYX INC (US) | 2018-09-27 | — | — | US | disclosed |
| EP-3356356-A1 | COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | Senomyx, Inc. (US) | 2018-08-08 | — | — | EP | disclosed |
| US-9732071-B2 | Compounds useful as modulators of TRPM8 | SENOMYX, INC. (US) | 2017-08-15 | — | — | US | disclosed |
| US-20170143022-A1 | Compositions Incorporating an Umami Flavor Agent | SENOMYX INC (US) | 2017-05-25 | — | — | US | disclosed |
| US-20170096418-A1 | COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | FIRMENICH INCORPORATED | 2017-04-06 | — | — | US | disclosed |
| US-20170087199-A1 | COMPOSITIONS FOR DELIVERING A COOLING SENSATION | SENOMYX INC (US) | 2017-03-30 | — | — | US | disclosed |
| US-20160376263-A1 | BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF | SENOMYX INC (US) | 2016-12-29 | — | — | US | disclosed |
| US-20110177545-A1 | G-PROTEINS | GIVAUDAN SA (CH) | 2011-07-21 | — | — | US | disclosed |
| US-20110097741-A1 | PARTIAL T1R2 NUCLEIC ACID SEQUENCE, RECEPTOR PROTEIN AND ITS USE IN SCREENING ASSAYS | GIVAUDAN SA (CH) | 2011-04-28 | — | — | US | disclosed |
| US-7919236-B2 | G-proteins | GIVAUDAN SA (CH) | 2011-04-05 | — | — | US | disclosed |
| US-20090176266-A1 | FUNCTIONAL METHOD TO IDENTIFY TASTANTS | GIVAUDAN S.A. (CH) | 2009-07-09 | — | — | US | disclosed |
| EP-2007805-A1 | NUCLEIC ACID, POLYPEPTIDE AND ITS USE | Givaudan SA (CH) | 2008-12-31 | — | — | EP | disclosed |
| EP-2008095-A1 | FUNCTIONAL METHOD TO IDENTIFY TASTANTS | Givaudan SA (CH) | 2008-12-31 | — | — | EP | disclosed |
| EP-1581555-B1 | CHIMERIC ALPHA Q-GUSTDUCIN G-PROTEINS | GIVAUDAN SA (CH) | 2008-04-30 | — | — | EP | disclosed |
| WO-2007121600-A1 | NUCLEIC ACID, POLYPEPTIDE AND ITS USE | GIVAUDAN SA (CH) | 2007-11-01 | — | — | WO | disclosed |
| WO-2007121599-A1 | FUNCTIONAL METHOD TO IDENTIFY TASTANTS | GIVAUDAN SA (CH) | 2007-11-01 | — | — | WO | disclosed |
| US-20060275765-A1 | G-proteins | GIVAUDAN SA (CH) | 2006-12-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110097741-A1 | PARTIAL T1R2 NUCLEIC ACID SEQUENCE, RECEPTOR PROTEIN AND ITS USE IN SCREENING ASSAYS | TAS2R30, TAS1R2, TAS2R31 | LGALS8 3210/4885CD209 2407/4885LGALS3 3831/4885 |
| US-20160376263-A1 | BITTER TASTE MODIFIERS INCLUDING SUBSTITUTED 1-BENZYL-3-(1-(ISOXAZOL-4-YLMETHYL)-1H-PYRAZOL-4-YL)IMIDAZOLIDINE-2,4-DIONES AND COMPOSITIONS THEREOF | TAS2R5, TAS1R1, TAS2R1 | LGALS8 1379/4885CD209 1991/4885LGALS3 1516/4885 |
| US-10392371-B2 | Compounds useful as modulators of TRPM8 | TRPM8, TRPM4, TRPM6 | LGALS8 407/4885CD209 3929/4885LGALS3 3855/4885 |
| US-20170143022-A1 | Compositions Incorporating an Umami Flavor Agent | TAS2R8, TAS2R45, TAS2R40 | LGALS8 580/4885CD209 2239/4885LGALS3 2243/4885 |
| US-20190177308-A9 | COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | TRPM8, TRPM6, TRPM4 | LGALS8 435/4885CD209 4030/4885LGALS3 4060/4885 |
| US-20180273517-A1 | COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | TRPM8, TRPM6, TRPM4 | LGALS8 435/4885CD209 4030/4885LGALS3 4060/4885 |
| US-20170087199-A1 | COMPOSITIONS FOR DELIVERING A COOLING SENSATION | TRPA1, PDE6G, PDE6D | LGALS8 1384/4885CD209 605/4885LGALS3 1884/4885 |
| US-20170096418-A1 | COMPOUNDS USEFUL AS MODULATORS OF TRPM8 | TRPM8, TRPM6, TRPM4 | LGALS8 435/4885CD209 4030/4885LGALS3 4060/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.